ABSTRACT. The two-body problem in general relativity is reduced to the problem of an effective particle (with an energy-dependent relativistic reduced mass) in an external field. The effective potential is evaluated from the Born diagram of the linearized quantum theory of gravity. It reduces to a Schwarzschild-like potential with two different 'Schwarzschild radii'. The results derived in a weak field approximation are expected to be relevant for relativistic velocities.1. In both non-relativistic and special relativistic mechanics, classical and quantum, the twobody problem for (spinless) point particles is reduced to the conceptually simpler problem of a single effective particle moving in an external field. The only exception to this picture so far seems to be the general theory of relativity, where the two-body problem has been treated in a considerably more complicated way: as a field-theoretic problem with singularities [1, 2] (or as a problem of finite size bodies interacting with a gravitational field [31). Here we propose to treat gravitational two-particle interaction in much the same way as electromagnetic interactions have been tackled previously [4,5] in the quasipotential approach [6] which found its natural place in the constraint Hamiltonian framework of References [7] and [8] . 1 Unlike other first-order (in 1/c 2 ) semi-relativistic treatments (based on a quantum field theoretic derivation of the two-particle potential) [12] , our approach is fully relativistic. Here we shall consider the two-body problem in the leading order of perturbation 1 Revised version of Trieste preprint IC/80/124 (August 1980)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.